137 related articles for article (PubMed ID: 24083243)
21. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
[TBL] [Abstract][Full Text] [Related]
22. Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.
Szabo Z; Kao PF; Burns HD; Gibson RE; Hamill TG; Ravert HT; Kim SE; Mathews WB; Musachio JL; Scheffel U; Dannals RF
J Nucl Med; 1998 Jul; 39(7):1209-13. PubMed ID: 9669396
[TBL] [Abstract][Full Text] [Related]
23. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
[TBL] [Abstract][Full Text] [Related]
24. Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats.
Hadizad T; Kirkpatrick SA; Mason S; Burns K; Beanlands RS; Dasilva JN
Bioorg Med Chem; 2009 Dec; 17(23):7971-7. PubMed ID: 19879152
[TBL] [Abstract][Full Text] [Related]
25. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
Le MT; Pugsley MK; Vauquelin G; Van Liefde I
Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
[TBL] [Abstract][Full Text] [Related]
27. 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET.
Plisson C; Gunn RN; Cunningham VJ; Bender D; Salinas CA; Medhurst AD; Roberts JC; Laruelle M; Gee AD
J Nucl Med; 2009 Dec; 50(12):2064-72. PubMed ID: 19910432
[TBL] [Abstract][Full Text] [Related]
28. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
[TBL] [Abstract][Full Text] [Related]
29. Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.
Chen YJ; Rosario BL; Mowrey W; Laymon CM; Lu X; Lopez OL; Klunk WE; Lopresti BJ; Mathis CA; Price JC
J Nucl Med; 2015 Aug; 56(8):1199-205. PubMed ID: 26045309
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 18F-FPyKYNE-Losartan for Imaging AT1 Receptors.
Hachem M; Tiberi M; Ismail B; Hunter CR; Arksey N; Hadizad T; Beanlands RS; deKemp RA; DaSilva JN
J Nucl Med; 2016 Oct; 57(10):1612-1617. PubMed ID: 27199365
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods.
Treyer V; Streffer J; Wyss MT; Bettio A; Ametamey SM; Fischer U; Schmidt M; Gasparini F; Hock C; Buck A
J Nucl Med; 2007 Jul; 48(7):1207-15. PubMed ID: 17574984
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors.
Arksey N; Hadizad T; Ismail B; Hachem M; Valdivia AC; Beanlands RS; deKemp RA; DaSilva JN
Bioorg Med Chem; 2014 Aug; 22(15):3931-7. PubMed ID: 25023539
[TBL] [Abstract][Full Text] [Related]
33. Characterization of [
Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
35.
Hoffmann M; Chen X; Hirano M; Arimitsu K; Kimura H; Higuchi T; Decker M
ChemMedChem; 2018 Dec; 13(23):2546-2557. PubMed ID: 30430750
[TBL] [Abstract][Full Text] [Related]
36. A PET Tracer for Renal Organic Cation Transporters, ¹¹C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
Jakobsen S; Busk M; Jensen JB; Munk OL; Zois NE; Alstrup AK; Jessen N; Frøkiær J
J Nucl Med; 2016 Apr; 57(4):615-21. PubMed ID: 26769859
[TBL] [Abstract][Full Text] [Related]
37. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
Cao Z; Kelly DJ; Cox A; Casley D; Forbes JM; Martinello P; Dean R; Gilbert RE; Cooper ME
Kidney Int; 2000 Dec; 58(6):2437-51. PubMed ID: 11115077
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves.
Reimold M; Mueller-Schauenburg W; Becker GA; Reischl G; Dohmen BM; Bares R
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):564-77. PubMed ID: 14689241
[TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
Clark KL; Robertson MJ; Drew GM
Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
